Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan®) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Han, Sang Hoon ^a   Kim, Seung Up ^a   Kim, Chang Oh ^a   Jeong, Su Jin ^a   Park, Jun Yong ^a   Choi, Jun Yong ^a   Kim, Do Young ^a   Ahn, Sang Hoon ^a   Song, Young Goo ^a   Han, Kwang Hyub ^a   Kim, June Myung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; DIDANOSINE; GAMMA GLUTAMYLTRANSFERASE; PROTEINASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CLINICAL EFFECTIVENESS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELASTOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREDICTION; PROSPECTIVE STUDY; SOUTH KOREA; TREATMENT DURATION;

ADULT; ANTI-RETROVIRAL AGENTS; COINFECTION; CROSS-SECTIONAL STUDIES; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; PROTEASE INHIBITORS;

EID: 84871902942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052720     Document Type: Article

References (27)

1. Hogg R, Lima V, Sterne JA, Grabar S, Battegay M, et al. (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372: 293-299.
2. Battegay M, Elzi L, (2009) Morbidity and mortality in HIV-infected individuals- a shift towards comorbidities. Swiss Med Wkly 139: 564-570.
3. Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, et al. (2009) Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation 119: 805-811.
4. Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, et al. (2008) Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS 22: 395-402.
5. Zucchetto A, Suligoi B, De Paoli A, Pennazza S, Polesel J, et al. (2010) Excess mortality for non-AIDS-defining cancers among people with AIDS. Clin Infect Dis 51: 1099-1101.
6. Phair J, Palella F (2011) Renal disease in HIV-infected individuals. Curr Opin HIV AIDS.
7. Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K, (2011) Increasing burden of liver disease in patients with HIV infection. Lancet 377: 1198-1209.
8. Aranzabal L, Casado JL, Moya J, Quereda C, Diz S, et al. (2005) Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 40: 588-593.
9. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, et al. (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29: 1705-1713.
10. Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, et al. (2011) Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 60: 977-984.
11. Merchante N, Perez-Camacho I, Mira JA, Rivero A, Macias J, et al. (2010) Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine. Antivir Ther 15: 753-763.
12. Kim SU, Choi GH, Han WK, Kim BK, Park JY, et al. (2010) What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int 30: 268-274.
13. WHO (2006) International Statistical Classification of Diseases and Related Health Problems. 10th Revision, 2nd ed. Geneva. World Health Organization.
14. CDC (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm. Rep 41: 1-19.
15. Jung KS, Kim SU, Ahn SH, Park YN, Kim do Y, et al. (2011) Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 53: 885-894.
16. Kim SU, Han KH, Ahn SH, (2010) Transient elastography in chronic hepatitis B: an Asian perspective. World J Gastroenterol 16: 5173-5180.
17. Vogel M, Rockstroh JK, (2007) Hepatotoxicity and liver disease in the context of HIV therapy. Curr Opin HIV AIDS 2: 306-313.
18. Li Vecchi V, Soresi M, Colomba C, Mazzola G, Colletti P, et al. (2010) Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients. World J Gastroenterol 16: 5225-5232.
19. Pineda JA, Gonzalez J, Ortega E, Tural C, Macias J, et al. (2010) Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients. J Viral Hepat 17: 714-719.
20. Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, et al. (2009) Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis 48: 963-972.
21. Stabinski L, Reynolds SJ, Ocama P, Laeyendecker O, Ndyanabo A, et al. (2011) High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antivir Ther 16: 405-411.
22. Grinspoon S, Carr A, (2005) Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352: 48-62.
23. Neuschwander-Tetri BA, (2005) Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci 330: 326-335.
24. Cooper CL, Parbhakar MA, Angel JB, (2002) Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 34: 1259-1263.
25. Bonfanti P, Ricci E, Penco G, Orofino G, Bini T, et al. (2005) Low incidence of hepatotoxicity in a cohort of HIV patients treated with lopinavir/ritonavir. AIDS 19: 1433-1434.
26. Sulkowski MS, Mehta SH, Chaisson RE, Thomas DL, Moore RD, (2004) Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir. AIDS 18: 2277-2284.
27. Roulot D, Czernichow S, Le Clesiau H, Costes JL, Vergnaud AC, et al. (2008) Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 48: 606-613.